Author： Doggrell Sheila A
Publisher： Informa Healthcare
ISSN： 1472-8222
Source： Expert Opinion on Therapeutic Targets, Vol.9, Iss.4, 2005-08, pp. : 875-877
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
`Plausible target' for new obesity therapies identified
Inpharma, Vol. 1, Iss. 1287, 2001-01 ,pp. :
Access to resources
Recommend
Ghrelin as a Potential Anti-Obesity Target
Current Pharmaceutical Design, Vol. 9, Iss. 17, 2003-07 ,pp. :
By Gartlon Jane Szekeres Philip Pullen Mark Sarau Henry Aiyar Nambi Shabon Usman Michalovich David Steplewski Klaudia Ellis Cathy Elshourbagy Nabil Duxon Mark Ashmeade Tracey Harrison David Murdock Paul Wilson Shelagh Ennaceur Abdel Atkins Alan Heidbreder Christian Hagan Jim Hunter A. Jones Declan
Psychopharmacology, Vol. 177, Iss. 1-2, 2004-12 ,pp. :
Shp2 as a therapeutic target for leptin resistance and obesity
Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 1, 2006-02 ,pp. :
Treatment of Obesity: Should We Target the Individual or Society?
Current Pharmaceutical Design, Vol. 9, Iss. 15, 2003-06 ,pp. :